Nucleus Life Trust's most recent trade in RPG Life Sciences Ltd. was a Acquisition of 4,412 Equity Shares done at an average price of Rs. 2207.2 . Disclosure was reported to the exchange on March 12, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Nucleus Life Trust in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RPG Life Sciences | Nucleus Life Trust (Revised) | Promoter Group | Acquisition | 12 Mar 2025 | 4,412 | 8,904,393 (53.84%) | 0.03% | 2207.2 | 9,738,144 | 29 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust (Revised) | Promoter Group | Acquisition | 12 Mar 2025 | 306 | 8,899,981 (53.81%) | 0.00% | 2085.7 | 638,232 | 28 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust (Revised) | Promoter Group | Acquisition | 12 Mar 2025 | 1,859 | 8,899,675 (53.81%) | 0.01% | 2100.2 | 3,904,266 | 28 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust (Revised) | Promoter Group | Acquisition | 12 Mar 2025 | 3,048 | 8,907,441 (53.86%) | 0.02% | 2188.0 | 6,668,879 | 29 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 26 Dec 2024 | 1,800 | 8,920,831 (53.94%) | 0.01% | 2187.4 | 3,937,250 | 24 Dec 2024 24 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 24 Dec 2024 | 2,012 | 8,918,137 (53.92%) | 0.01% | 2195.4 | 4,417,107 | 20 Dec 2024 20 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 24 Dec 2024 | 874 | 8,919,021 (53.93%) | 0.01% | 2174.2 | 1,900,269 | 23 Dec 2024 23 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 24 Dec 2024 | 10 | 8,919,031 (53.93%) | 0.00% | 2170 | 21,700 | 23 Dec 2024 23 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 24 Dec 2024 | 10 | 8,918,147 (53.92%) | 0.00% | 2196 | 21,960 | 20 Dec 2024 20 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 20 Dec 2024 | 500 | 8,915,876 (53.91%) | 0.00% | 2233 | 1,116,500 | 18 Dec 2024 18 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 20 Dec 2024 | 249 | 8,916,125 (53.91%) | 0.00% | 2197.2 | 547,105 | 19 Dec 2024 19 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 18 Dec 2024 | 330 | 8,915,376 (53.91%) | 0.00% | 2254.1 | 743,837 | 17 Dec 2024 17 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 18 Dec 2024 | 200 | 8,915,046 (53.90%) | 0.00% | 2270.1 | 454,010 | 16 Dec 2024 16 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 16 Dec 2024 | 235 | 8,911,185 (53.88%) | 0.00% | 2280.7 | 535,969 | 12 Dec 2024 12 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 16 Dec 2024 | 720 | 8,914,846 (53.90%) | 0.00% | 2253.7 | 1,622,681 | 13 Dec 2024 13 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 16 Dec 2024 | 2,941 | 8,914,126 (53.89%) | 0.02% | 2258.7 | 6,642,936 | 13 Dec 2024 13 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 09 Dec 2024 | 34 | 8,910,903 (53.88%) | 0.00% | 2170.9 | 73,810 | 05 Dec 2024 05 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 09 Dec 2024 | 10 | 8,910,950 (53.88%) | 0.00% | 2190 | 21,900 | 06 Dec 2024 06 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 09 Dec 2024 | 37 | 8,910,940 (53.88%) | 0.00% | 2187.9 | 80,952 | 06 Dec 2024 06 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 09 Dec 2024 | 793 | 8,910,869 (53.87%) | 0.00% | 2174.7 | 1,724,557 | 05 Dec 2024 05 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 05 Dec 2024 | 25 | 8,907,466 (53.86%) | 0.00% | 2197 | 54,925 | 02 Dec 2024 02 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 05 Dec 2024 | 2,595 | 8,910,066 (53.87%) | 0.02% | 2200.4 | 5,710,042 | 03 Dec 2024 03 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 05 Dec 2024 | 5 | 8,907,471 (53.86%) | 0.00% | 2200 | 11,000 | 02 Dec 2024 02 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 05 Dec 2024 | 10 | 8,910,076 (53.87%) | 0.00% | 2200 | 22,000 | 03 Dec 2024 03 Dec 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 02 Dec 2024 | 306 | 8,899,981 (53.81%) | 0.00% | 0 | 0 | 28 Nov 2024 28 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 02 Dec 2024 | 3,048 | 8,907,441 (53.86%) | 0.02% | 0 | 0 | 29 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 02 Dec 2024 | 4,412 | 8,904,393 (53.84%) | 0.03% | 0 | 0 | 29 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 02 Dec 2024 | 1,859 | 8,899,675 (53.81%) | 0.01% | 0 | 0 | 28 Nov 2024 28 Nov 2024 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 09 Feb 2023 | 2,261 | 8,872,155 (53.64%) | 0.01% | 82.9 | 187,408 | 07 Feb 2023 07 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 09 Feb 2023 | 6,301 | 8,878,456 (53.68%) | 0.04% | 844.8 | 5,323,113 | 08 Feb 2023 08 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 08 Feb 2023 | 151 | 8,864,801 (53.60%) | 0.00% | 672 | 101,472 | 12 Aug 2022 12 Aug 2022 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 08 Feb 2023 | 5,093 | 8,869,894 (53.63%) | 0.03% | 813.2 | 4,141,501 | 06 Feb 2023 06 Feb 2023 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 11 Aug 2022 | 21,000 | 8,864,650 (53.60%) | 0.13% | 694.9 | 14,593,634 | 10 Aug 2022 10 Aug 2022 |
Insider Trading | Equity Shares | Market Purchase |
| RPG Life Sciences | Nucleus Life Trust | Promoter Group | Acquisition | 11 Aug 2022 | 7,706 | 8,843,650 (53.47%) | 0.05% | 683.0 | 5,263,018 | 08 Aug 2022 08 Aug 2022 |
Insider Trading | Equity Shares | Market Purchase |